Valuation: Eurofins Scientific SE

Market Cap 12.94B 265B 14.56B 12.08B 11.01B 20.76B 1,400B 20.95B 146B 56.64B 716B 54.68B 53.49B 2,297B P/E 2026 *
24.9x
P/E 2027 * 19.6x
Enterprise Value 16.31B 334B 18.35B 15.22B 13.87B 26.16B 1,764B 26.41B 184B 71.37B 902B 68.9B 67.41B 2,895B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 2.01x
Free-Float
60.39%
Yield 2026 *
1.08%
Yield 2027 * 1.22%
3 years 999.5
Extreme 999.5
1,061.06
5 years 959.22
Extreme 959.22
1,397.02
10 years 959.22
Extreme 959.22
1,397.02
Manager TitleAgeSince
Chief Executive Officer 63 01/01/1987
Director of Finance/CFO - 01/01/2015
Corporate Officer/Principal 54 01/10/2019
Director TitleAgeSince
Chairman 63 01/01/1987
Director/Board Member 60 01/01/2015
Director/Board Member 60 01/01/1990
Change 5-day change 1-year change 3-year change Capi.($)
+6.16%-.--% - - 14.57B
+4.16%+3.04%+49.37%+94.17% 74.41B
-3.11%-3.53%+21.92%+74.60% 59.26B
+0.89%-0.63%+4.28%+34.51% 47.14B
-1.02%-4.52%+26.33%+33.14% 42.91B
-0.17%+0.86%+352.39%+689.99% 44.13B
-1.54%-2.17%+2.28%+97.78% 40.79B
-0.54%+2.93%+9.50%+50.41% 30.77B
-2.68%+5.11%+33.11%+19.50% 29.31B
+0.51%-7.18%-28.42%+331.10% 23.71B
Average +0.26%-0.64%+52.31%+158.36% 43.6B
Weighted average by Cap. +0.14%-0.40%+57.43%+150.06%

Financials

2026 *2027 *
Net sales 7.54B 154B 8.48B 7.03B 6.41B 12.09B 815B 12.2B 85.13B 32.99B 417B 31.85B 31.16B 1,338B 7.94B 163B 8.94B 7.41B 6.76B 12.75B 860B 12.86B 89.73B 34.77B 439B 33.57B 32.84B 1,410B
Net income 531M 10.86B 598M 496M 452M 852M 57.44B 860M 6B 2.32B 29.37B 2.24B 2.19B 94.24B 660M 13.5B 742M 616M 561M 1.06B 71.38B 1.07B 7.45B 2.89B 36.49B 2.79B 2.73B 117B
Net Debt 3.37B 68.87B 3.79B 3.14B 2.86B 5.4B 364B 5.45B 38.02B 14.73B 186B 14.22B 13.91B 598B 3.03B 62.07B 3.41B 2.83B 2.58B 4.87B 328B 4.91B 34.27B 13.28B 168B 12.82B 12.54B 539B
Logo Eurofins Scientific SE
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2025, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (52,5%), North America (36.8%) and other (10.7%).
Employees
65,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
74.54EUR
Average target price
72.01EUR
Spread / Average Target
-3.40%

Quarterly revenue - Rate of surprise